
Please try another search
Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother’s risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Name | Age | Since | Title |
---|---|---|---|
Kim Puloma Kamdar | 56 | 2011 | Independent Chairman |
Evguenia Lindgardt | 49 | 2021 | President, CEO & Director |
Gregory C. Critchfield | 72 | 2011 | Executive Director |
Joshua S. Phillips | 57 | 2011 | Independent Director |
Robert H. Getzenberg | - | - | Member of Scientific Advisory Board |
Amos E. Madanes | - | - | Member of Scientific Advisory Board |
C. Matthew Peterson | - | - | Member of Scientific Advisory Board |
D. Ware Branch | - | - | Member of Scientific Advisory Board |
Robert M. Silver | - | - | Member of Scientific Advisory Board |
Sandra A. J. Lawrence | 67 | 2021 | Independent Director |
David G. Grenache | - | - | Member of Scientific Advisory Board |
Mansoor Raza Mirza | 64 | 2014 | Independent Director |
Jane F. Barlow | 64 | 2022 | Independent Director |
Jeffrey T. Elliott | 47 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review